# MRI and Dose Selection in a Phase II Trial of Baricitinib with Conventional Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis

> Research article (The Journal of Rheumatology, 2019) · cited 15× · AI/ML

**Wikidata**: [openalex:W2908721391](https://www.wikidata.org/wiki/openalex:W2908721391)  
**Source**: https://4ort.xyz/entity/mri-and-dose-selection-in-a-phase-ii-trial-of-baricitinib-with-conventional-synthetic-disease-modifying-antirheumatic-dr